SCHEMBL30228557

SCHEMBL30228557

[2H]C([2H])([2H])NC(=O)CN(c1ccc2c(-c3ccccc3C)cc(=O)oc2c1)C([2H])([2H])[2H]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 2/20 0.43
▸ IGLV6-57 P01721 5/20 0.42
▸ TDP1 Q9NUW8 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ CA12 O43570 3/20 0.37
▸ CA9 Q16790 3/20 0.37
▸ LMNA P02545 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228424 0.95 IGLV6-57 (0.39) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228212 0.95 IGLV6-57 (0.46) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228309 0.95 KCNA3 (0.43) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228289 0.88 IGLV6-57 (0.48) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228420 0.88 KCNA3 (0.41) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228144 0.85 IGLV6-57 (0.43) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228447 0.84 KCNA3 (0.44) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30228277 0.83 IGLV6-57 (0.38) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1
SCHEMBL30227938 0.80 IGLV6-57 (0.51) KCNA3IGLV6-57ALDH1A1L3MBTL1HPGD
SCHEMBL30228269 0.80 IGLV6-57 (0.46) KCNA3IGLV6-57TDP1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326732-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-10-23 — — US disclosed
WO-2023034346-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326732-A1 CHROMEN-2-ONE MODULATORS OF POLRMT POLRMT, TFAM, POLM KCNA3 4258/4885IGLV6-57 4814/4885TDP1 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback